Some Stem Cell Experts Want Out of Documentary After Funding Source Revealed
By Erin Allday,
San Francisco Chronicle
| 06. 15. 2019
A new documentary about stem cell therapy is being questioned by some of those who appear in it — prominent cellular scientists who say they weren’t aware of who was backing the project when they agreed to participate.
The 10-part series is set to launch online Monday. The filmmakers said they may delay the premiere because some people interviewed for the project no longer want to be involved, after learning that the movie was funded in part by for-profit stem cell providers who are under federal investigation. Some scientists said they fear the documentary may promote what they consider junk science.
A five-minute trailer for “The Healthcare Revolution” is online at the website www.healthcarerev.org, where a surprisingly deep lineup of “expert sources” in stem cells is listed along with the institutions they represent.
Among the scientists named is Dr. Maria Millan, head of the California Institute for Regenerative Medicine, the state’s stem cell funding agency. Also named are three consumer stem cell providers who have been sued by the U.S. Food and Drug Administration to stop their operations; one...
Related Articles
By Jenny Lange, BioNews | 12.01.2025
A UK toddler with a rare genetic condition was the first person to receive a new gene therapy that appears to halt disease progression.
Oliver, now three years old, has Hunter syndrome, an inherited genetic disorder that leads to physical...
By Rachel Hall, The Guardian | 11.20.2025
Couples are needlessly going through IVF because male infertility is under-researched, with the NHS too often failing to diagnose treatable causes, leading experts have said.
Poor understanding among GPs and a lack of specialists and NHS testing means male infertility...
By Pam Belluck and Carl Zimmer, The New York Times | 11.19.2025
Gene-editing therapies offer great hope for treating rare diseases, but they face big hurdles: the tremendous time and resources involved in devising a treatment that might only apply to a small number of patients.
A study published on Wednesday...
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
